A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Clinical trial NCT05687032 · COMPLETED
Trial details
- NCT number
- NCT05687032
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-24
- Primary completion
- 2024-08-07
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.